---
category: news
title: "Lantheus Acquires Rights to Innovative Imaging Biomarker Targeting Fibroblast Activation Protein (FAP) from Noria"
excerpt: "Lantheus Holdings, Inc. (NASDAQ: LNTH) (Lantheus), an established leader and fully integrated provider of innovative imaging diagnostics, targeted the"
publishedDateTime: 2021-03-30T16:29:00Z
originalUrl: "https://www.businesswire.com/news/home/20210330005613/en/Lantheus-Acquires-Rights-to-Innovative-Imaging-Biomarker-Targeting-Fibroblast-Activation-Protein-FAP-from-Noria"
webUrl: "https://www.businesswire.com/news/home/20210330005613/en/Lantheus-Acquires-Rights-to-Innovative-Imaging-Biomarker-Targeting-Fibroblast-Activation-Protein-FAP-from-Noria"
type: article
quality: 0
heat: 0
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI in Healthcare
  - AI

secured: "FIU1D358Cx5X/WYi761Ah+IzNNjZ6AK7VRDcLggn4QiU3t3/HoYcYUf9msSCxWQ/734I71R6sxOPmqcZFDosqqWriCQj7S32Ixk+AULjPxV9s2+oq+AfIddwjj/QeVSyZDBHyuVeqA4t//knxOrQN50xWK9TuNYRHcLOCsoZhRvcxS3WcQSN1sIS9CKc0YgCMWVFufFkwtmfObLbz907Dmuio8fjhR83KGo7enXC3eTQ+r+WADflbIBqRybbFDMYovgwVy++LfOPna3R3pe4HJ67YO2qmzBq8xo+vSGYT/A3FMOwfTQ4lGdaEzwJxLTc9zMqOaKl6uq7dNjxaJ9CVHtyDzNDf0qatiH9tG/HWS8=;C+kMIGZIjTCKRoxK2AiSwA=="
---

